SAN FRANCISCO (MarketWatch) -- Boston Scientific Corp. on Monday said two studies showed a composite 98.1% procedural success rate by its second-generation FilterWire EZ Embolic Protection System in ...
Natick-based Boston Scientific Corp. has been given the go-ahead from the U.S. Food and Drug Administration to market its FilterWire EX Embolic Protection System to treat saphenous vein graft (SVG) ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
WASHINGTON, DC – OCTOBER 16, 2008 – Results of a study on the use of the FiberNet® Embolic Protection System in carotid artery stenting were reported today during the 20th annual Transcatheter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results